| Dataset 1 | Dataset 2 |
---|
Controls | Non-freezers | Freezers | Freezers |
---|
Age | 65 ± 6.8 | 67 ± 7.4 | 69 ± 7.4 | 67 ± 9.3 |
PD duration |  | 7.8 ± 4.8 | 9.0 ± 4.8 | 10 ± 6.3 |
MMSE [81] | 29 ± 1.3 | 29 ± 1.2 | 28 ± 1.1 | 28 ± 1.3 |
UPDRS III [82] |  | 34 ± 9.9 | 38 ± 14 | 39 ± 12 |
H&Y [83] |  | 2.4 ± 0.3 | 2.5 ± 0.5 | 2.4 ± 0.5 |
- The subject characteristics of the fourteen healthy control subjects (controls), fourteen PwPD and without FOG (non-freezers), fourteen PwPD and FOG (freezers) of dataset 1, and seventeen PwPD and FOG (freezers) of dataset 2 at the baseline assessment. All characteristics are given in terms of mean ± standard deviation. For dataset 1, the characteristics were measured during the ON-phase of the medication cycle, while for dataset 2 the characteristics were measured while OFF medication